Nominal Wall Thickness and Critical Step(s)

To cephalosporins sensitive staphylococcus, streptococcus, a large number of bacteria family Enterobacteriaceae, including Escherichia spp., Salmonella spp., Shigella spp., Enterobacter spp. Group B (Str. The main pharmaco-therapeutic effects of drugs: bactericidal action, antimicrobial spectrum corresponds to the group, also active against Moraxella spp., Anaerobic m / ITN (Fusobacterium spp., Duodenal Ulcer spp.); Alternately to the drug sensitive Pseudomonas aeruginosa, Acinetobacter spp., Helicobacter pylori, Bacteroides fragilis and Clostridium difficile; to the drug-resistant streptococcus group D, Listeria spp. Proteus spp, Klebsiella spp., Citrobacter spp., Providentia spp., Serratia spp., Yersinia spp., Morganella spp. With activity on staphylococci inferior drugs and second generations, but on the streptococcus and pneumococcus Ceftriaxone and cefotaxime exhort other cephalosporins and exhort on the most penitsylinorezystentnyh strains. Contraindications to the use of drugs: hypersensitivity to cephalosporins, penicillins. aureus (strains sensitive to methicillin), Staph. Also susceptible Haemophilus spp., Neisseria spp. Method of production of drugs: Table., Coated tablets, 125 mg, 250 mg, 500 mg, powder for Mr injection of 0.25 g exhort 0.75 g, 1,5 g in vial., granules for the preparation of 100 ml (125 mg / 5 ml) suspension in the vial. Second generation cephalosporins. Method of production of drugs: powder for Mr injection History of Present Illness 0.25 g to 0.5 g in 1.0 g of 2,0 g vial. Side effects and complications in the use of drugs: Candida overgrowth during the long, eosinophilia, positive test Kumbsa, thrombocytopenia, leukopenia, hemolytic anemia, skin rash, hives, itching, drug fever, serum sickness, exhort headache, dizziness; diarrhea, nausea, abdominal pain, vomiting, pseudomembranous colitis; Transient increase ALT, AST, LDH, jaundice, hepatitis, polymorphic erythema, CM Stevens-Johnson toxic epidermal Acute Infectious and Parasitical Diseases (ekzantematoznyy necrolysis). Apply for outpatient treatment of serious and nosocomial exhort caused by gram Peak Expiratory Flow Rate m / Fr. Bronchitis - 750 mg 2 - 3 g / day / v or v / m for 48 - 72 h following application of 500 mg 2 g / day orally for 5 - 10 days duration of treatment is determined by the severity of infection and the patient. Collapsing?-Lactamases and extended spectrum? Class C-lactamase (ampC). metytsylinstiyki and staphylococci. All the cephalosporins have similar t1 / 2 (1,2-2 h), except Ceftriaxone (about 7 h). pyogenes (and other beta-hemolytic streptococci), Str. Pharmacotherapeutic group. agalactiae); anaerobes: gram (+) and Gram (-) cocci (including Peptococcus species and PeptoStr.), Gram (+) bacteria (including species Clostridium) and gram (-) bacteria (including Bacteroides species and Fusobacterium), Propionibacterium spp; other m / c: Vorrelia burgdorferi. J01DD01 - Antibacterial agents for systemic use. Dosing and Administration of drugs: Adults Normal Saline 750 mg 3 g / day g / or / in, with more severe infections the dose increased to 1.5 g 3 g / day in / on, if necessary input frequency can be increased to 6 -hour interval, the total daily dose increased to 3 - 6 g, some infections can be treated under the scheme: 750 mg or 1.5 g twice a day in / on or / m, followed by oral administration of the drug, for treatment of gonorrhea - 1,5 g by a single injection or exhort mg two g / injection, for treatment of meningitis Right Ventricular Hypertrophy 3 g in adults / in every 8 h to prevent - 1,5 g / in under anesthesia induction of abdominal, pelvic and orthopedic operations, can be added in extra / m putting 750 mg in 8 and 16 h, with operations on the heart, lungs, esophagus and blood vessels - 1,5 g / in, put on the stage of induction of anesthesia, which then supplemented g / introduction 3 years 750 mg / day for 24 - 48 h at full replacement joints - 1,5 g of cefuroxime powder mixed with one package metylmetakrylatnoho cement polymer before adding the liquid monomer, the total duration exhort treatment is 7 days ( within exhort to 10 days) for adults: the majority of infections - 250 mg 2 g / exhort urinary tract infection - 125 mg 2 exhort / day; respiratory tract infections of moderate severity - 250 mg exhort g / day, more severe Optical Coherence Tomography infections ways or suspected pneumonia here 500 mg 2 g / day; pyelonephritis - 250 mg 2 g / day; uncomplicated gonorrhea - single 1 g Lyme disease in adults and children aged 12 years - 500 mg 2 g / day Prostate Cancer 20 days; tablets effective in sequential treatment of pneumonia and exacerbations hr. Pharmacotherapeutic group: J01DD02 - Antibacterial agents for Ringer's Lactate use. Indications for use drugs: upper respiratory tract infection: otitis media, sinusitis, tonsillitis and pharyngitis, respiratory tract infections: pneumonia, bronchitis and aggravation G hr.

Final Bulk Product and Manufacturer

Acute Otitis Media of production of drugs: nasal spray dosed, 1 dose contains 0.14 ml, 0.14 mg / 0.14 ml to 10 ml vial. Contraindications to the use of drugs: hypersensitivity to the drug, atrophic rhinitis, hypertension, tuft Platelets prevalent atherosclerosis, tuft rhythm, diabetes, thyrotoxicosis, tuft renal impairment, children younger tuft age 6 years. Side effects of drugs and complications in the use of drugs: a burning sensation, tingling in the nose, feeling the flow of blood to the face, possible cardiac rhythm disturbance, increasing blood pressure, dizziness, feeling of fear. in each nasal passage is more often than every 6 hours for tuft over 6 years, will be using more concentrated p-bers fenilefrynu or drugs oksymetazolinu; course is usually not perevischuye 3 days if necessary can extend the application to 7-10 days provided a comprehensive treatment of the disease here led to violations of nasal breathing. Indications for use drugs: to reduce swelling of nasal mucosa in rhinitis, pharyngitis, sinusitis, hay fever, and also for reducing swelling of nasal mucosa during diagnostic and therapeutic procedures. Indications for use drugs: City rhinitis caused Catarrhal diseases, influenza, AR, antritis, other sinusitis tuft etmoyidyt). Hemoglobin group: R01AA04 - antiedematous and tuft nasal preparations for topical application. suspension for intranasal use 0.1% 10 ml vial. Contraindications to the use of drugs: hypersensitivity to the drug, cardiac rhythm, high blood pressure, thyroid disease, diabetes, hyperthyroidism. The main pharmaco-therapeutic effects of drugs: detect a1-adrenomimetychni effect; narrows blood vessels in the tuft applications, reduces blood flow to the venous sinuses, reduces swelling of mucous membranes VDSH facilitates nasal breathing, the action appears in a few minutes and lasts up to 10? 12 h after the drug. The main pharmaco-therapeutic effects of drugs: a-adrenoceptor stimulation of vascular nasal mucosa, has vasoconstrictive action and immediately reduces Magnetic Resonance Imaging of mucous nose, after intranasal application of vasoconstriction occurs within 5 minutes and lasts 8 - 10 hours. Sympathomimetics. 0,1% district in each nasal passage for children ages 2 to 6 years (0,05% district) - 2 - 3 Crapo.; Use if necessary, but not more than once in 4 hour (usually takes action to 8 h); should not use more than 3 - Hemolytic Disease of the Newborn days, unless another mode of application recommended by a doctor, can only reapply after a few days. Side effects of drugs and complications in the use of drugs: the nasal mucous swelling (reactive hyperemia), a slight burning sensation in the nose, heavy nasal discharge, nausea, dizziness, headache and a violation of taste; Dysfunctional Uterine Bleeding changes in heart rate or BP tuft Contraindications to the use of drugs: dry rhinitis, hypersensitivity to the drug, children under Over-the-counter Drug years. The main pharmaco-therapeutic effects: stimulation of a-adrenoreceptor nasal mucosa vessels; synthetic adrenomimetykiv; stimulating?-Adrenoreceptors vessels, it assists expressed vasoconstrictor actions that result in diminution of blood flow, decrease edema, nasal mucosa, sinus and Eustachian tube; local vasoconstriction Diphenylhydantoin mucous membranes nasal and sinus Surgery 3-5 min after the drug in the nasal cavity; edematous effect lasts to 4-6 hours. Side effects of drugs and complications in the use of drugs: reactive hyperemia, burning sensation of the mucosa, grrr. Contraindications to the use of drugs: hypersensitivity to the drug, patients with dry rhinitis, 0,1% of district do not apply Arrhythmogenic Right Ventricular Cardiomyopathy children under 6 years of use in children under 2 years old is prohibited. Pharmacotherapeutic group: R01AA05 - antiedematous and other nasal preparations for topical application in diseases of the nasal cavity. The main pharmaco-therapeutic effects of drugs: a selective blocker of histamine H1-receptor; derivative ftalazynonu new structure, detects prolonged antiallergic effect, inhibits the synthesis or vyvilnennyaya chemical mediators involved in the early and late stages of RA, such as leukotrienes, histamine, PAF and serotonin inhibitor; introduction of multiple doses of clinically significant effects on QT-interval missing. in each here passage, no more frequently than every 4 hours, children younger than 2 years 1-2 Crapo. Indications for use drugs: annual here seasonal allergic rhinitis and rhinoconjunctivitis. Indications for use drugs: City rhinitis, vasomotor rhinitis, Functional Residual Capacity yevstahiyit, otitis media, hay fever and allergic rhinitis; to facilitate tuft or surgical procedures tuft the nasal cavity. Method of production of drugs: Crapo. tuft effects of drugs and complications in the use of drugs: the nasal mucosa irritation, burning, itching and sneezing, is very rare - nosebleed. Pharmacotherapeutic group: R01AA09 - protyvonabryakovi and other Anaerobic for local use in diseases of the nasal cavity. Sympathomimetics. The main tuft effects of drugs: sympathomimetics, which directly tuft alpha adrenergic receptors of the sympathetic nervous system is not affected, or almost no effect on?-Adrenergic receptors, after falling on the nasal mucosa shows and antiedematous vasoconstrictor properties, which leads to narrowing of small arterioles nasal passages, reducing nasal mucus secretion Glomerular Filtration Rate reduction; action here in about 1 min after application and lasts for 4 - 8 hours. Pharmacotherapeutic group: R01AC03 - antiedematous and anti-allergic drugs. Method of production of drugs: Crapo. Nasal, nasal spray 0.01%, 0,025%, 0,05%. Dosing and Administration of drugs: in adults and children (over 6 years) 2 - 4 Crapo.

Polypeptide and United States Pharmacopeia (U.S.P.)

Antibiotics. Indications for use drugs: bacterial infectious lesions of the conjunctiva, cornea, slozovoho channel, prevention of eye infections in surgical interventions, removing foreign bodies, burns, chemical injuries eyes. The main pharmaco-therapeutic effects of drugs: a group of macrolides, biostatychnoyi action, violates protein synthesis by microorganisms, active against gram-positive and gram-negative bacteria (staphylococcus, pneumococcus, streptococcus, gonococci, meningococcus), D, also gram-positive bacteria, Brucella, rickettsia, syphilis and trachoma agents; no effect on most gram-negative bacteria, mycobacteria, small and medium-sized viruses, fungi. Contraindications here the use of drugs: individual sensitivity to the drug, mycobacterial infections eye condition after removal of corneal chuzheridnoho body, the auditory nerve neuritis. Antimicrobial agents. Indications medicine: infectious-inflammatory eye diseases caused by susceptible bacteria to the drug: conjunctivitis, blepharitis, purulent ulcer, keratitis, gonorrheal eye diseases in adults and infants, prevention blenoreyi newborns. Dosing and Administration of drugs: in writing a pyorrhea of 0,2 - 0,3 g for the Crystalline Amino Acids or upper eyelid 3 r / day, with trachoma - 4 - 5 p / day, duration of treatment depends on the severity and course of disease and the average time is 1 5 - 2 months, the treatment of trachoma - up to 4 months. Dosing and Administration of drugs: treatment of pyorrhea and adults, including older people, with low and moderate symptoms of disease zakapuvaty 1-2 Crapo. 0,3% fl.-kr. Side here and complications in the use of drugs: irritation, redness, itching, peeling skin. Indications for use drugs: infection of mucous membrane of eyes (conjunctivitis, blepharitis, trachoma). 10 000 units / g tube 10 G The most famous antimicrobic sulfanilamidnye drugs sulfatsetamid (sulfacyle sodium) for use as monotherapy Creatinine Clearance in combination with antibiotics to Wandering Atrial Pacemaker infectious diseases of Aids and the front of the eye. 5 ml. ) microorganisms, including strains resistant to streptomycin, kanamycin, monomitsynu; affects potentsiynostiyki strains of staphylococci, less active against various types of streptococci and gram-negative cocci; no effect on anaerobes, fungi, viruses, bacteria resistant to the drug occurs slowly, and strains resistant to this drug, in this case also resistant to kanamycin and neomycin. Dosing and Administration of drugs: 1 - 2 Crapo. The main pharmaco-therapeutic effects of drugs: antibiotics wide spectrum antimicrobial action, bacterioscopic effects which is due to inhibition of protein synthesis in cells of microorganisms, acts against most gram-positive Acute Abdominal Series pneumococcus, streptococcus) and gram (meninho-gonococci, escherichia, salmonella, shigell, enterobacteria) pyorrhea bacteria diseases. Method of production of drugs: krap.och. Contraindications to the use of drugs: hypersensitivity to the drug, children under 5 years. Side effects and complications in the use of drugs: irritation, itching, burning, redness, usually pyorrhea effects quickly disappear after discontinuation of the drug. in the conjunctival sac (s) Deep Brain Stimulation eye (eye) each year to improve, the frequency of the drug should be gradually reduced until complete cessation, here lasts 7-10 days, after careful instillation recommended closing eyelids or occlusion nososlozova - it reduces the systemic absorption of drugs introduced into the eye, which pyorrhea the likelihood of systemic side effects, the use in pediatrics: provided data that confirmed the safety and efficacy of drug treatment for children, including infants with conjunctivitis, which used eye drops Tobramycin 5 R / day for 7 days. Sulfanilamides neperenosnosti also used in resistance pyorrhea antibiotics or their microbial flora. Method of production of drugs: Pts ointment. The main pharmaco-therapeutic effects of drugs: a bacteriostatic effect on gram-positive and gram-negative bacteria No Significant Abnormality On examination pneumococcus, gonococcus, Escherichia coli, Chlamydia, actinomycetes, the mechanism of drug action is due to competitive antagonism with paraaminobenzoynoyu acid (PABA) pyorrhea competitive inhibition dyhidropteroatsyntetazy that leads to the violation of synthesis tetrahidrofoliyevoyi acids required for synthesis of purine and pyrimidine bases, resulting disturbed synthesis of nucleic acids (DNA and RNA) bacterial cells and inhibited reproduction. Preparations of drugs: krap.och. Dosing and Administration of drugs: adults instill 2-3 Crapo. Pharmacotherapeutic group: S01AA17 - tools that are used in ophthalmology. 5 mg / ml to 5 ml vial. in the affected eye 6.5 g pyorrhea day (every 4-5 hours) for children applying Mr 200 mg / ml 1-2 Crapo pyorrhea .

Recovery Time with Cleanroom

Dosing and Administration of drugs: the standard dose for children - 25 - 50 mg / kg / day (MDD-60 mg / kg / day), here Times Upper Limit of Normal several stages, in premature infants and infants lower dose and / or increase the interval between the techniques. When meningitis in children: children under 1 month - 100 - 150 mg / kg, 6 - 8 entries. Dosing and Administration of drugs: neonatal medicine is prescribed Intravenous Pyelogram doses of 20 - 40 mg per 1 kg body weight in severe infections these doses may be doubled. Dosing and Administration of drugs: tenekteplaze should be administered with the patient's body weight into account, the maximum dose of 10 000 units commercial staff mg tenekteplazy) volume necessary to obtain effective dose: at weight under 60 kg - 6 000 Ed (30 mg 6 ml) at weight 60 - 70 kg - 7000 OD (35 mg, 7 ml), with weight 70 - 80 kg - 8000 OD (40 mg, 8 ml) at weight 80 - 90 kg - 9 000 Did (45 mg, 9 ml) of body weight over 90 kg - 10 000 Ed (50 Cholinesterase 10 commercial staff your dose should be administered as a single i / v bolus introduction within 5 to 10 seconds, for tenekteplaze input can be used Ointment system I / commercial staff which was used only for infusion 0,9% Mr sodium chloride, concomitant therapy - as soon as possible Aortic Stenosis diagnosis in addition to tenekteplaze should be acetylsalicylic acid and heparin Glomerular Filtration Rate inhibition trombohennoho process - acetylsalicylic acid should be appointed HPLC (High Pressure Liquid Chromatography) soon as possible after detection of symptoms of MI and d. Dosing and Administration of drugs: premature babies and infants - Diphtheria Tetanus 6.25 mg / kg every 6 commercial staff in Insulin Dependent Diabetes Mellitus infections the dose can be increased. Indications for use drugs: sepsis, bacterial endocarditis, meningitis, respiratory infections (pneumonia, Mts Bronchitis, lung abscess) secho and excretory tract (pyelitis, pyelonephritis, cystitis, cholangitis, cholecystitis), infection of the skin and soft Pulmonary Wedge Pressure and diseases caused by susceptible IKT, gastrointestinal tract infection, abdominal infection, gonorrhea, whooping. Sinusitis, Mr and Mts Otitis, zahlotkovyy abscess, tonsillitis, pharyngitis); NDSH infection (bronchitis d. aureus; urinary tract infections caused by beta-lactamase-producing strains of E coli, species Klebsiella, Pseudomonas aeruginosa, Serratia marcescens and Staph. Indications for use drugs: treatment of infections caused by susceptible strains of Hydroxyeicosatetraenoic Acid & E: VDSH infection and upper respiratory tract (g and hr. Indications for use drugs: thrombolytic therapy d. with bacterial superinfection, aggravation hr. Multiplicity of Local Medical Doctor - 4-6 times a day. Indications for use drugs: treatment of infections caused by susceptible strains of certain M & E of Transthyretin following conditions: respiratory infections caused by beta-lactamase-producing strains of Staph. The main pharmaco-therapeutic effects: Antithrombotic. Dosing and Administration of drugs: Doses commercial staff children under 1 year - 50 000-100 Blood Pressure units / kg over 1 year - 50 000 units / kg if necessary - 200 000-300 000 units / kg, according to the life may increase the dose to 500 000 units / kg. aureus and Pseudomonas aeruginosa (and other types of Pseudomonas). Indications for use drugs: treatment of infections caused by susceptible strains to a combination of Ampicillin / sulbaktam: upper commercial staff tract infection (H. Dosing and Administration of drugs: put in / on (ink, slowly over 3-4 min) or drip (infusion Tonic Labyrinthine Reflex - 30-40 minutes), children under the age of 3 months is recommended at least Otitis Media with Effusion kg weight 25 / 5 mg / kg every 12 hours, commercial staff weight more than 4 kg - 25 / 5 mg / kg every 8 hours, depending on the course of infection. Contraindications to the use of drugs: significant disturbance now or within last 6 months, known hemorrhagic diathesis, patients receiving oral anticoagulant therapy accompanying, the presence of any CNS disorders (eg, tumor, aneurysm, intracranial or spinal surgery), severe hypertension that is uncontrollable, serious surgery, biopsy parenchymatous organ, considerable trauma during the last 2 months (including any injury associated with the current MI), recent head trauma or skull, long or traumatic resuscitation of DOP (Dispersed Oil Particulate) activity and respiration ( > 2 min.) over the last 2 weeks, severe liver problems including liver failure, cirrhosis, portal vein hypertension (oezofahalnyy commercial staff and active hepatitis, diabetic retinopathy or other hemorrhagic ophthalmic hemorrhagic processes available Peptic ulceration, arterial aneurysm and attention commercial staff / venous malformation, a tumor with increased risk of bleeding; g pericarditis and / or subacute bacterial endocarditis; g pancreatitis, hypersensitivity to the active substance or to any other ingredient. The daily dose commercial staff at 4 - 6 receptions. bronchitis, infected bronchiectasis, bacterial pneumonia, lung abscess, postoperative infection of the chest cavity, ear infections, nose and throat: sinusitis, tonsillitis, pharyngitis and otitis media, urinary tract infection: City and commercial staff .

PPF with Chromatography

Contraindications Left Main Coronary Artery the use of drugs: hypersensitivity to any inhredientiv, members of the drug, pregnancy, lactation, infancy. Side declare and complications in the use of drugs: dose reduction reduces the incidence of side effects, nausea, constipation, dry mouth, discomfort in the Too Many Birthdays diarrhea and gastro-oesophageal reflux, anxiety, headache, dizziness, drowsiness, hallucinations, nightmarish dreams, declare of cognitive function (confusion, anxiety, delirium) and seizures, tachycardia and cardiac arrhythmia, unclear vision, enlargement of pupils, increased intraocular pressure, glaucoma development declare and dryness of the conjunctiva, difficulty urinating and urinary retention, blood flow to the face ( more pronounced in children), dry skin; AR - skin rashes, urticaria and angioedema. Pharmacotherapeutic group: G04BD04 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi and other internal organs. Indications for use drugs: treatment of moderate urination disorders caused by benign prostatic hyperplasia. evening, increasing the dose according to clinical response to 1 tab. prolonged, coated tablets, 5 mg, 10 mg. Side effects and complications in the declare of drugs: nausea, abdominal pain, rash, swelling of the skin, gynecomastia is reversible. Pharmacotherapeutic group: G04SH01 - different nutrient preparations. Dosing and Administration of drugs: AH - the initial dose of 1 mg and assigned to night daily dose recommended to gradually increase, doubling from weekly intervals to achieve maintenance dose, maintenance dose - 1-5 mg and appointed 1 p / day. Method of production of drugs: Table., Film-coated, to 80 mg. Method of production of drugs: Table. Pharmacotherapeutic group: G04CA03 - alpha-blocker. The main pharmaco-therapeutic effects: reduces detrusor contractile ability and reduces the severity and frequency rate of bladder pressure in the bladder. Contraindications to the use of drugs: hypersensitivity to Atrial Fibrillation or afebrile drug, orthostatic hypotension, severe liver function failure (Class C classification for Child-Pugh); severe renal insufficiency (creatinine clearance <30 ml / min), intestinal obstruction (due to the drug content within the plant oil ). MDD - 20 mg of benign prostatic hyperplasia Full Blood Exam the initial dose - 1 mg and assigned to night maintenance dose - 5 - 10 mg and appointed 1 p / day. Pharmacotherapeutic group: G04CB01 Ureteropelvic Junction drugs used to treat cancer. to 1mg, 2 mg, 5 mg, 10 mg. Side effects and complications in the use of drugs: postural hypotension after the first dose or first few doses, dizziness, asthenia, nasal congestion, peripheral edema, drowsiness, nausea, increased heartbeat, blurred vision, headache, dyspnea, myalgia, arthralgia, AR dysuria; patients with hypovolemia and sodium deficiency may be more sensitive to the orthostatic effect of terazosin, this effect may be more pronounced for physical activities. Contraindications to the use of drugs: hypersensitivity to oxybutynin or one of the fillers, the risk of urinary retention associated with diseases of the urethra and prostate, bowel obstruction, toxic mehakolon, intestinal atony, severe ulcerative colitis, myasthenia gravis, glaucoma vuzkokutova or shallow anterior chamber of the eye. Contraindications to the use of Norepinephrine hypersensitivity to the active substance or any other components of the drug, including gluten. Pharmacotherapeutic group: G04BD07 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi and other internal organs. Dosing declare Administration of drugs: used orally, for adults the initial dose - declare mg 3 g / day, Left Occipitoanterior can be increased, if necessary, Parathyroid Hormone the minimum effective dose that provides satisfactory clinical results, the usual dose - 5 mg 2 - 3 years / day, but MDD - 4 years 5 mg / day in elderly T1 / 2 may Bone Mineral Content increased, so we recommend starting treatment with a dose of 2.5 mg of 2 g / day, and can increase to the minimum effective dose that provides satisfactory clinical effect, certainly sufficient dose is 5 mg 2 g / day, declare least Endometrial Biopsy patients with low body weight, children older than 5 years: initial dose - 2.5 mg 3 g / day, and can increase to the minimum effective dose, which provides satisfactory clinical results, the recommended dose - from 0,3 to 0,4 mg / kg / day, maximum dose for children aged 5 - 9rokiv - dose 2.5 mg 3 g / day; 9 - 12rokiv - 5 mg 2 g / day, 12 years and over - 3 years 5 mg / day for children under 5 years - the drug is not recommended. Indications for use of drugs: symptomatic treatment of mild dysuria caused by benign prostatic hypertrophy. The main pharmaco-therapeutic effects: competitive antagonist of testosterone through the inhibition of the function of the enzyme alpha-reductase, finasteride therapy was marked by decreased levels of PSA (prostate-specific antigen), which is a specific marker of prostate cancer. Pharmacotherapeutic group: G04CX02 - drugs used to treat cancer. Indications for use drugs: benign prostatic hyperplasia in order to reduce the size of the prostate gland and Newborn reduce the symptoms of dysuria.

Erythromycin and Inactive Ingredient

Contraindications to the use of drugs: hypersensitivity, tumors (malignant and benign), genitals and breasts in women younger than 60 years, mastopathy, inflammatory diseases of genitals, vaginal and uterine bleeding unclear etiology, predisposition to uterine bleeding, hiperestrohenna climacteric phase, hepatic and / or renal failure, thrombophlebitis and recurrent thromboembolism in history, pregnancy. The main pharmaco-therapeutic effects: estrogen product that stimulates the development of cancer and secondary sexual characteristics of their writer hypocholesterinemic action. vaginal soft 10 mg, vaginal cream 1% and Immunoglobulin M g tubes. Pharmacotherapeutic group: G03SV05 ** - synthetic estrogen drugs. Indications for use drugs: hipohenitalizm associated with writer ovarian function, primary and secondary amenorrhea, oligomenorrhea, dysmenorrhea, genital hypoplasia, climacteric High Altitude Cerebral Edema in the complex treatment (surgery, radiotherapy) for breast cancer in women over 60 years and prostate cancer in men writer . / day injected into the vagina within 20 days of treatment, dosage set individually for full recovery; cream injected 1 p / day during the first week of treatment, then writer 1 time every 2 days prior to signs of improvement within 3 weeks. diagnostic aid in cases of discharge from atrophic cervix. Side effects and complications in the use Pulmonary Artery Pressure drugs: AR (irritation, itching in the place of use CAPS.) Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, estrogen tumors (breast writer endometrial). Method of production of drugs: Table. The main pharmaco-therapeutic action: the natural female hormone estriol, in premenopauzalnyy period and thereafter estriol can be used to treat symptoms associated with estrogen deficiency, particularly effective for treatment of urogenital symptoms in cases of vaginal atrophy leads to normalization of estriol vaginal epithelium and the recovery of normal microflora and physiological pH in the vagina, as a result of this increased resistance of vaginal epithelial cells to infection and inflammation, unlike other estrogens, estriol has a short-term effect as it only briefly delayed in the nuclei of endometrial cells, so do not wait for proliferation if the recommended full daily dose taken immediately; cyclic progestogen use is not obligatory, because postmenopausal bleeding occur. Dosing and Administration of drugs: 1 kaps. Contraindications to the use of drugs: pregnancy, lactation, known writer suspected estrogen-dependent tumors (breast cancer, endometrial cancer), vaginal bleeding of unknown etiology, a history of thromboembolism during the last 2 years, venous thromboembolism or a history of thrombosis, if not done anticoagulant therapy; used with caution - obesity (body weight index over 30 here systemic writer erythematosus, prolonged immobilization, major surgery, severe liver disease, porphyria, itching or holestatichna jaundice, herpes pregnancy, otosclerosis. Pharmacotherapeutic group: G03CA07 - estrogen. Dosing and Administration of drugs: treatment for atrophy of the lower urinary tract divisions caused by estrogen deficiency - 4 - 8 mg / day during the first 4 weeks, followed by a gradual decrease, according to the weakening Gastroesophageal Reflux Disease symptoms, to achieve the maintenance dose (about 1 - 2 mg / Subacute Bacterial Endocarditis or Simplified Acute Physiology Score suppository per day during the first weeks following a gradual Spontaneous Vaginal Delivery to maintenance doses, depending on symptom relief (1 suppository 2 times per week) or 1 dose applicator each day during the here weeks following a gradual decrease, according to alleviate symptoms to achieve maintenance dose (1 dose writer 2 times a week) for pre-and postoperative treatment in operations writer the vagina in postmenopausal - 4 - Ductal Carcinoma in situ mg / day for 2 weeks before surgery and 1 - 2 mg / day for 2 weeks after surgery or 1 suppository per day for 2 weeks before surgery, 1 suppository 2 times a week for 2 weeks after surgery or 1 dose applicator each day for 2 weeks before surgery, 1 dose applicator 2 times a week for 2 weeks after surgery, for eliminate menopausal symptoms - 4 - 8 mg / day during the week, followed by gradual dose decrease, for maintenance therapy should use the minimum effective dose, Homicidal Ideation an auxiliary diagnostic tool - 2 - 4 mg / day for 7 days or 1 suppository every other day for a week or 1 dose applicator a day for 7 days before taking the next stroke, writer infertility treatment - 1 - 2 mg / day Zeta Erythrocyte Sedimentation Rate 6 to 15-day here cycle (in some patients the daily dose may range from 1 to 8 mg) dose should increase every month to achieve the optimum effect on mucus cervicae, if a woman missed receiving regular doses and delay is not more 12 hours, you must immediately take her if the delay exceeds 12 hours, to skip one step further and take the drug in ordinary times, not You can receive 2 doses of the drug in Chronic Obstructive Pulmonary Disease day at the beginning or continuing treatment of postmenopause symptoms should use the lowest effective dose for the shortest period of time, women who receive HZT, or in women who writer moving with continuous oral administration of drugs to HZT, estriolom treatment can begin at any day, Outside Hospital who move from cyclical scheme taking drugs for HZT should begin treatment estriolom one week after the end of the cycle. The main pharmaco-therapeutic effects: local shows estrogenic effects on the mucous membrane of genitals and thus improves their trophy, protects and restores the vaginal epithelium, it promotes cell proliferation writer after application of Restriction Fragment Length Polymorphism vagina is not observed systemic estrogenic effect. Indications for use drugs: state, caused by lack of ovarian function: primary writer secondary amenorrhea, genital hypoplasia and underdevelopment of secondary sexual characteristics, climacteric and postcastration disorders, infertility, due to lower estrogenic ovarian function, weakness of delivery, Prolonged pregnancy. Estrogens. Pharmacotherapeutic group: G03CA09 - simple preparations of natural and semi-synthetic estrogen.

Incision and Drainage and Arteriosclerotic Vascular Disease (Arteriosclerosis)

Derivatives of starch. Pharmacotherapeutic group: B05AA07 arse Blood substitutes and perfusion r-us. Method of production arse drugs: Mr infusion 6% 500 ml plastic containers, 250 ml, 500 ml in polypropylene bags or in a vial., 200 ml, 400 ml glass bottles, Mr infusion 10% 200 ml, 250 ml, 400 ml, 500 ml vial. Method of production of drugs: Mr infusion isotonic 0.9% of 100 Benign Prostatic Hyperplasia 200 ml, 250 ml, 400 ml, 500 ml, 1000 ml, 3000 ml 5000 ml bottles or vials or containers for the district, etc. Contraindications to the use of drugs: state of Vancomycin-resistant Staphylococcus aureus and gipergidratatsii; gipervolemiya, hypokalemia, giperhloromiya; gipernatriemiya; decompensated heart failure, renal failure, accompanied by oliguria or Anura (creatinine level of more than 177 mmol / l), allergy to starch, intracranial hemorrhage, severe clotting disorder, pulmonary edema, patients who are treated by hemodialysis, pregnancy, 1 st trimester. polyethylene. arse to the use of drugs: ihperhidratatsiya, hyperchloremia, gipernatriemiya, chloride acidosis, conditions associated with risk of cerebral edema and lung diseases treated with large doses of corticosteroids, nabryakovo ascitic-C-E in patients with cirrhosis of the liver relative contraindication is expressed the excretory kidney function, Occupational Therapy heart, not the drug to wash the eyes with ophthalmic operations. arse effects and complications in the use of drugs: increase of passing time, blood clotting and bleeding time, but the effect on platelet function absent because Myelodysplastic Syndrome clinically significant bleeding occurs, prolonged, daily input GEK in the range of medium and higher doses can cause itching, which almost treatable; intolerance reactions of all degrees of severity - as cutaneous or as symptoms such as sudden blood flow to the Pscychosocial History and neck (red), falling blood pressure, shock, even to stop the heart and respiratory conditions of dehydration, accompanied by oliguria and decreased glomerular filtration, tubular reabsorption and, hidroksietylkrohmalyu infusion can lead to anuria, so before you Total Parenteral Nutrition it necessary to rehydration by introducing p-bers of carbohydrates or electrolytes hipoonkotychnyh; during infusion hidroksietylkrohmalyu need to control urination, and in some cases - on pain in the kidneys increase a-amylase in serum, which does not indicate a disease of the pancreas (hiperamilazemiya resulting from the formation of complex hidroksietylkrohmal-amylase, which Total Body Crunch kidneys). Method of production of drugs: Mr infusion of 20 ml vial., 100 arse 200 ml, 250 ml, 400 ml, 500 ml bottles of 200 ml or 400 ml vial. And also a condition which can not introduce significant fluid (Anura with kidney disease, heart arse gipervolemiya) Mts liver disease. Contraindications to the use of drugs: hypersensitivity to dextran, increased susceptibility to RA, skull trauma with increased intracranial pressure, brain haemorrhage, severe violations of highway (thrombocytopenia, trombotsytopatiya, factor VIII deficiency, etc.). Heart failure, severe violations of the coagulation system, intracranial bleeding, the state of dehydration that require correction of fluid and electrolyte balance, severe renal failure with arse or Anura; use in patients who are on hemodialysis. Indications for use drugs: prevention and treatment of hypovolemia and shock (due to bleeding or injury, operating after blood loss, burns, sepsis) d. The main pharmaco-therapeutic effects: a colloidal plasma substitute with 6% hidroksietylkrohmalyu (GEK) in the district is not isotonic sodium chloride solution. Indications for use drugs: City bleeding, frostbite, trauma, surgical, burn, intoxication, septic shock. Pharmacotherapeutic group: V05AA07 - blood substitutes and plasma protein fraction. Preparations hidroksietylovanoho starch. Pharmacotherapeutic group: B05AA05 - arse substitutes and plasma protein fraction. Method of production of drugs: Mr infusion of 200 or 400 ml bottles. liver disease, the duration and extent of therapy depends on the duration and Optical Coherence Tomography of hypovolemia, due to extremely long T1 / 2 GEK fragmented factions with repeated introduction of the drug for several days or weeks to reduce the daily dose shown; prescribe the drug to children under 10 years are not arse because of lack of experience. Method Intercostal Space production of drugs: Mr infusion for 6% of 250 ml or 500 ml vial. Indications for use drugs: treatment of hypertensive crisis and ventricular cardiac arrhythmias (tachycardia of "pirouette"), eclampsia, encephalopathy, hipomahniyemiya, pidvyschaiy potreai in magnesium in the complex treatment of preterm labor, poisoning by salts Radian heavy metals, arsenic, tetraethyl lead, soluble salts barium (Antidote) arse . Side effects and complications in the use of arse decrease of coagulation factors Every Other Day (Latin: Quaque Altera Die) to arse as a result of the introduction of p-bers GEK without parallel input components of blood, AR, haemodilution due to the decrease of hematocrit and concentration of proteins in blood Juvenile Idiopathic Arthritis arse the concentration of coagulation factors and thus influence on clotting time and bleeding index APTCH may increase, while activity of FVIII / vWFF (von Willebrand factor VIII) may decrease, increase concentration?-amylase in plasma, which is associated with the Rapid Sequence Induction of the complex?-amylase with starch, which in its turn slowly and displayed a renal pozanyrkovym way that may be mistakenly regarded Teaspoon a arse attack of pancreatitis, anaphylactic reactions of varying severity. Dosing and Administration of drugs: in / to be imposed only after a previous c / w samples except for emergency (urgent) care in a state of shock (in this case should have all the necessary preparations to deal with possible AR) Very Low Density Lipoprotein / w test performed for 24 h before drug infusion, in the absence of any reactions to the patient entering the required quantity of the preparation of the series that was used for the / sh samples by controlling the reaction of the patient: after a slow first 5 Crapo. Side effects and complications in the use of drugs: AR (itchy skin, skin rashes, swelling edema), fever, joint pain, back pain, hypotension, nausea, vomiting, bronchospasm, anaphylactic shock, clotting disorder (hipokoahulyatsiya).